MabGenesis is a biopharmaceutical startup that delivers first-in-class and best-in-class therapeutic monoclonal antibodies using technologies established by 30+ years of academic research. By using the innovative technology platform, high-quality phage display antibody libraries (MOURA Libraries) and efficient antibody isolation technology (IMPACT), MabGenesis makes it possible to isolate 100% species-specific monoclonal antibodies rapidly and efficiently. MabGenesis is a private company headquartered in Yokohama, Japan. For more information, visit https://mabgenesis.com/en
Company Details
- Employees
- 3
- Founded
- -
- Address
- 3-7-18 Shin-Yokohama, Kohoku-Ku, Yokohama,kanagawa 222-0011,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mabgenesis.com/en
- Keywords
- Biotechnology, Antibody, Monoclonal antibody, VHH, membrane protein, Canine, Feline, GPCR, Autoimmune diseases, Cancer, Inflammatory diseases, Phage display antibodies, Antibodydiscovery.
- HQ
- Yokohama, Kanagawa
Mabgenesis Inc. Questions
Mabgenesis Inc.'s website is https://mabgenesis.com/en
Mabgenesis Inc.'s LinkedIn profile is https://jp.linkedin.com/company/mabgenesis-inc-new
Mabgenesis Inc. has
3 employees.
View email and phone details for 3
employees at Mabgenesis Inc..
Mabgenesis Inc.'s industry is
Biotechnology Research
Mabgenesis Inc.'s top competitors are
The Chicken Vet,
Natural Remedies - Pet Care,
Curelabs,
Livisto Polska,
アルフレッサ（株）,
Samurai Cell株式会社,
Tpx Solutions,
Cargill,
White Crow Inc.,
Trainvet Co.
Mabgenesis Inc.'s categories are Biotechnology Research
Mabgenesis Inc.'s founding year is 2019
